Flawed, scandalous trials tank FDA skilled assist for MDMA remedy

MDMA pills up close.

Enlarge / MDMA capsules up shut. (credit score: Getty | Common Historical past Archive)

After a remarkably sensational regulatory drug assessment, advisers for the Meals and Drug Administration on Tuesday voted overwhelmingly in opposition to approving midomafetamine (MDMA, aka ecstasy or molly) as a part of remedy for post-traumatic stress dysfunction.

In a response to the query, “Do the accessible information present that the drug is efficient in sufferers with posttraumatic stress dysfunction?” advisers voted 9 “no” to 2 “sure” in opposition to MDMA.

The votes come after a full-day assembly through which the unbiased skilled advisers heard detailed critiques of scientific trial information from the corporate that proposed the remedy—Lykos, previously MAPS—in addition to inside FDA critiques.

Learn eight remaining paragraphs | Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *